Fulgent Genetics, Inc. (FLGT) stock
FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$24.21+0.14 (+0.56%)
Close on Nov 17, 2026Market cap $666.15MP/E –Yield –
Fulgent Genetics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Fulgent Genetics's total debt was $1.48M at Jun 30, 2026. For fiscal 2025 it was $1.96M, down 21.5% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.96M | -21.5% |
| FY2024 | Dec 31, 2024 | $2.49M | -15.9% |
| FY2023 | Dec 31, 2023 | $2.96M | -12.1% |
| FY2022 | Dec 31, 2022 | $3.37M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.48M | -24.6% |
| Q1 FY2026 | Mar 31, 2026 | $1.48M | -24.6% |
| Q4 FY2025 | Dec 31, 2025 | $1.96M | -21.5% |
| Q3 FY2025 | Sep 30, 2025 | $1.96M | -21.5% |
| Q2 FY2025 | Jun 30, 2025 | $1.96M | -21.5% |
| Q1 FY2025 | Mar 31, 2025 | $1.96M | -21.5% |
| Q4 FY2024 | Dec 31, 2024 | $2.49M | -15.9% |
| Q3 FY2024 | Sep 30, 2024 | $2.49M | -26.1% |
| Q2 FY2024 | Jun 30, 2024 | $2.49M | -58.1% |
| Q1 FY2024 | Mar 31, 2024 | $2.49M | -57.7% |
| Q4 FY2023 | Dec 31, 2023 | $2.96M | – |
| Q4 FY2022 | Dec 31, 2022 | $3.37M | – |
| Q3 FY2021 | Sep 30, 2021 | $5.95M | – |
| Q2 FY2021 | Jun 30, 2021 | $5.90M | – |
See a number that looks wrong?